Bio Green Med Solution (BGMS) Cash & Equivalents Growth (1y) (2011 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 23.56% |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 23.05% |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 71.81% |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 34.71% |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 84.98% |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 53.39% |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 28.50% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -57.58% |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | -11.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.86% |
| Mar 31, 2026 | -4.60% |
| Dec 31, 2025 | 11.73% |
| Sep 30, 2025 | 27.93% |
| Jun 30, 2025 | -28.33% |
| Mar 31, 2025 | 25.00% |
| Dec 31, 2024 | -7.13% |
| Sep 30, 2024 | -49.53% |
| Jun 30, 2024 | -41.18% |
| Mar 31, 2024 | -75.51% |
| Dec 31, 2023 | -81.59% |
| Sep 30, 2023 | -74.93% |
| Jun 30, 2023 | -64.95% |
| Mar 31, 2023 | -61.42% |
| Dec 31, 2022 | -49.82% |
| Sep 30, 2022 | -41.06% |
| Jun 30, 2022 | -33.32% |
| Mar 31, 2022 | -37.99% |
| Dec 31, 2021 | 9.44% |
| Sep 30, 2021 | 73.88% |